Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Education & Training

  • Fellowship Program, Pediatric Hematology/Oncology, 2007
    Texas Children's Hospital-Baylor College of Med.
  • Residency Program, Pediatrics, 2004
    Children's Hospital of the King's Daughters
  • Internship Program, Pediatrics, 2002
    Children's Hospital of the King's Daughters
  • MD, 2001
    Eastern Virginia Medical School
  • BA, 1995
    University of Virginia

Board Certifications

  • American Board of Pediatrics/Hematology-Oncology

National Provider ID: 1023215944


Biography

Lindsay Kilburn, M.D., comes to Children's National Health System from Texas Children’s Hospital in Houston, TX, where she was an assistant professor of pediatrics in the neuro-oncology and pharmacology programs. 

Dr. Kilburn graduated with a degree in Environmental Sciences from the University of Virginia. After graduating from Eastern Virginia Medical School, she completed her pediatric training at the Children’s Hospital of The King’s Daughters in Norfolk, VA, and her hematology/oncology fellowship at Texas Children’s Hospital/Baylor College of Medicine in Houston, TX. She also has received training in pharmacology from both Thomas Jefferson University in Philadelphia and the Baylor College of Medicine in Houston. Her research focuses on the development and evaluation of new therapeutic agents for children with pediatric brain tumors through clinical trials. She is committed to the improvement of palliative and supportive care. Dr. Kilburn grew up outside of Philadelphia and is married with young twins. Outside of work, she enjoys sailing, hiking, and traveling with her family.

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

Outside Interests

  • Pediatric Brain Tumor Consortium 

Clinical Assessment of Differential Diagnosis of the Child with Suspected Cancer

(0001) For Principles and Practice of Pediatric Oncology

Glutathione STransferase M1 and T1 Polymorphisms May Predict Adverse Effects After Therapy in Children with Medulloblastoma

(2009) Neuro Oncol

Intrathecal Chemotherapy

(0001) Handbook of Anticancer Agents Pharmacokinetics and Pharmacodynamics

Plasma and Cerebrospinal Fluid Pharmacokinetics of Tasidotin ILX651 and its Metobolites in NonHuman Primates

(2009) Cancer Chemother Pharmacol